Pluristem Therapeutics Inc. RESTRICTED STOCK AGREEMENT Made as of the _____________________________Restricted Stock Agreement • September 7th, 2016 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances)
WHEREAS, on March 29, 2016, the Company duly adopted and the Compensation Committee approved the 2016 Equity Compensation Plan and on May 31, 2016, the Company’s stockholders approved the adoption of the 2016 Equity Compensation Plan, a copy of which has been made available to the Optionee, forming an integral part hereof (the “Plan”); and
Pluristem Therapeutics Inc. STOCK OPTION AGREEMENT Made as of the _______________Stock Option Agreement • September 7th, 2016 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances)
WHEREAS, on March 29, 2016, the Company duly adopted and the Compensation Committee approved the 2016 Equity Compensation Plan and on May 31, 2016, the Company’s stockholders approved the adoption of the 2016 Equity Compensation Plan, a copy of which has been made available to the Optionee, forming an integral part hereof (the “Plan”); and
Pluristem Therapeutics Inc. RESTRICTED STOCK AGREEMENT Made as of the __________________Restricted Stock Agreement • September 7th, 2016 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances)
WHEREAS, on March 29, 2016, the Company duly adopted and the Compensation Committee approved the 2016 Equity Compensation Plan and on May 31, 2016, the Company’s stockholders approved the adoption of the 2016 Equity Compensation Plan, a copy of which has been made available to the Optionee, forming an integral part hereof (the “Plan”); and
